CoreCap Advisors »

Pharmacyte Biotech shares owned by CoreCap Advisors

Quarter-by-quarter ownership of Pharmacyte Biotech shares owned by CoreCap Advisors from 13F filings

Historical chart of CoreCap Advisors investment in Pharmacyte Biotech

Tip: Access up to 7 years of quarterly data

All positions including Pharmacyte Biotech held by CoreCap Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pharmacyte Biotech by CoreCap Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $3 4 0.75

More positions owned by CoreCap Advisors

Vanguard Total Stock Market Etf Etf (VTI)
State Street Spdr Portfolio S&p 500 Growth Etf Etf (SPYG)
State Street Technology Select Sector Spdr Etf Etf (XLK)
Vanguard Total Bond Market Etf Etf (BND)
Invesco S&p 500 Equal Weight Etf Etf (RSP)
Invesco Qqq Trust Series I Etf (QQQ)
Vanguard S&p 500 Etf Etf (VOO)
Schwab U.s. Small-cap Etf Etf (SCHA)
Apple Stock (AAPL)
Goldman Sachs Marketbeta U.s. Equity Etf Etf (GSUS)
Vanguard Value Etf Etf (VTV)
Nvidia Corporation Stock (NVDA)
State Street Spdr Portfolio S&p 500 Value Etf Etf (SPYV)
Ishares Core S&p 500 Etf Etf (IVV)
State Street Spdr S&p 500 Etf Etf (SPY)

View all positions for CoreCap Advisors

Top funds holding Pharmacyte Biotech

CoreCap Advisors
Harbour Investments
Caldwell Sutter Capital
Fortitude Family Office
Huntington National Bank

View all funds holding Pharmacyte Biotech